VOLORIDGE INVESTMENT MANAGEMENT, LLC - LIGAND PHARMACEUTICALS INC ownership

LIGAND PHARMACEUTICALS INC's ticker is LGND and the CUSIP is 53220K504. A total of 325 filers reported holding LIGAND PHARMACEUTICALS INC in Q1 2018. The put-call ratio across all filers is 1.44 and the average weighting 0.4%.

Quarter-by-quarter ownership
VOLORIDGE INVESTMENT MANAGEMENT, LLC ownership history of LIGAND PHARMACEUTICALS INC
ValueSharesWeighting
Q3 2023$484,633
-58.5%
8,088
-50.1%
0.00%
-66.7%
Q2 2023$1,168,813
-34.5%
16,211
-33.2%
0.01%
-33.3%
Q1 2023$1,784,271
+111.5%
24,256
+92.1%
0.01%
+80.0%
Q4 2022$843,550
-48.5%
12,628
+7.5%
0.01%
-54.5%
Q3 2021$1,637,000
-76.7%
11,749
-78.0%
0.01%
-77.6%
Q2 2021$7,019,000
-44.6%
53,504
-35.6%
0.05%
-46.7%
Q1 2021$12,666,000
+433.3%
83,080
+247.8%
0.09%
+360.0%
Q4 2020$2,375,000
+169.0%
23,886
+157.8%
0.02%
+185.7%
Q3 2020$883,000
-62.6%
9,265
-56.1%
0.01%
-74.1%
Q2 2020$2,360,000
-21.4%
21,103
-48.9%
0.03%
-68.6%
Q1 2020$3,003,000
+31.1%
41,296
+88.0%
0.09%
+91.1%
Q4 2019$2,290,000
-34.1%
21,962
-37.1%
0.04%
-25.0%
Q3 2019$3,473,000
+10.7%
34,889
+27.0%
0.06%
-31.0%
Q2 2019$3,137,000
+20.3%
27,482
+32.5%
0.09%
+10.1%
Q1 2019$2,607,000
-52.7%
20,741
-48.9%
0.08%
-68.4%
Q4 2018$5,513,000
-31.9%
40,628
+4.0%
0.25%
+15.2%
Q2 2018$8,091,000
+38.6%
39,054
+10.5%
0.22%
+58.4%
Q1 2018$5,836,000
+155.3%
35,338
+110.4%
0.14%
+168.6%
Q3 2017$2,286,000
-57.2%
16,792
-62.5%
0.05%
-66.7%
Q2 2016$5,336,00044,7430.15%
Other shareholders
LIGAND PHARMACEUTICALS INC shareholders Q1 2018
NameSharesValueWeighting ↓
Knott David M Jr 115,000$6,8912.63%
VILLERE ST DENIS J & CO LLC 438,161$26,254,6072.24%
RICE HALL JAMES & ASSOCIATES, LLC 282,961$16,955,0231.08%
Chicago Capital, LLC 360,345$21,591,8841.01%
CARDINAL CAPITAL MANAGEMENT LLC /CT 206,399$12,367,4280.53%
Smith, Graham & Co., Investment Advisors, LP 61,849$3,705,9920.46%
Stephens Investment Management Group LLC 467,564$28,016,4350.46%
Jackson Creek Investment Advisors LLC 13,657$8180.34%
Court Place Advisors, LLC 15,133$906,7690.32%
Ziegler Capital Management, LLC 123,158$7,379,1760.30%
View complete list of LIGAND PHARMACEUTICALS INC shareholders